...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: AGM - Jan 7, 2016 - Details
10
Jan 08, 2016 10:43AM
7
Jan 12, 2016 07:15PM
1
Jan 12, 2016 10:50PM
3
Jan 13, 2016 05:08PM
1
Jan 14, 2016 10:03AM
3
Jan 14, 2016 10:25AM
1
Jan 14, 2016 11:25AM

Whatever the start date, Don (from Masila's notes) said... "We are hoping to see results by the summer."

Realistically, I'll be looking for results in the fall.

4
Jan 14, 2016 03:17PM
5
Jan 15, 2016 01:08AM
3
Jan 15, 2016 09:24AM
Share
New Message
Please login to post a reply